IPO-33 research compound

IPO-33 — Research Compound Information

Product name: IPO-33
Category:  (synthetic opioid–cannabinoid hybrid)

this studied in laboratory and analytical settings for its interaction with both opioid and cannabinoid receptor systems. Due to this dual activity profile, IPO-33 is primarily referenced in scientific research focused on receptor binding, pharmacological modelling, and analytical identification.

The compound is typically used as a reference material in controlled research environments, including academic, forensic, and analytical laboratories.

Intended research use IPO-33 research compound

• Analytical and forensic reference applications

• Scientific and academic research

• Method development and compound identification

Important notice

IPO-33 is not approved for human or veterinary use. This compound is intended strictly for research and analytical purposes only. Handling and study should be performed exclusively by qualified professionals in appropriate laboratory environments and in compliance with all applicable laws and regulations.

Primary Keywords

• IPO-33 chemical information

• IPO-33 analytical reference

• Hybrid opioid cannabinoid compound

Secondary / Supporting Keywords

• Opioid cannabinoid research compound

• Receptor-binding research compound

• Laboratory research chemicals

• IPO-33 laboratory analysis

• Synthetic research compound